Characterization of biofilm matrix, degradation by DNase treatment and evidence of capsule downregulation in Streptococcus pneumoniae clinical isolates
Open Access
- 1 January 2008
- journal article
- Published by Springer Science and Business Media LLC in BMC Microbiology
- Vol. 8 (1), 173
- https://doi.org/10.1186/1471-2180-8-173
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Switch from planktonic to sessile life: a major event in pneumococcal pathogenesisMolecular Microbiology, 2006
- Direct Detection of Bacterial Biofilms on the Middle-Ear Mucosa of Children With Chronic Otitis MediaJAMA, 2006
- Phenotypic Characterization ofStreptococcus pneumoniaeBiofilm DevelopmentJournal of Bacteriology, 2006
- Characterization, Distribution, and Expression of Novel Genes among Eight Clinical Isolates of StreptococcuspneumoniaeInfection and Immunity, 2006
- Moxifloxacin and Azithromycin but not Amoxicillin Protect Human Respiratory Epithelial Cells against Streptococcus pneumoniae In Vitro when Administered up to 6 Hours after ChallengeAntimicrobial Agents and Chemotherapy, 2005
- Nasal Colonization with Streptococcus pneumoniae Includes Subpopulations of Surface and Invasive PneumococciInfection and Immunity, 2005
- Illustration of Pneumococcal Polysaccharide Capsule during Adherence and Invasion of Epithelial CellsInfection and Immunity, 2005
- Bacterial Biofilms: A Common Cause of Persistent InfectionsScience, 1999
- Association of Intrastrain Phase Variation in Quantity of Capsular Polysaccharide and Teichoic Acid with the Virulence ofStreptococcus pneumoniaeThe Journal of Infectious Diseases, 1998
- Molecular Analysis of Bacterial Pathogens in Otitis Media With EffusionJAMA, 1995